Comprehensive heart failure treatment at Livasa Hospital including medical therapy, device therapy and advanced options for reduced and preserved ejection fraction. Call +91-80788 80788.
Content:
Heart failure is a complex clinical syndrome affecting millions globally, characterized by the heart's inability to pump sufficient blood to meet the body's metabolic demands. Modern heart failure management at Livasa Hospital employs evidence-based approaches combining optimal medical therapy, device therapies and advanced treatment options to improve symptoms, reduce hospitalisations and improve survival.
Heart failure results from various causes leading to either reduced systolic function (HFrEF) or preserved systolic function (HFpEF):
Heart Failure with Reduced Ejection Fraction (HFrEF):
Ejection fraction <40 percent
Primarily systolic dysfunction
Common causes: CAD, hypertension, cardiomyopathy, valve disease
Heart Failure with Preserved Ejection Fraction (HFpEF):
Ejection fraction ≥50 percent
Primarily diastolic dysfunction
Common in elderly, hypertensive, diabetic patients
Both forms result in similar symptoms but have different pathophysiology and treatment approaches.
Heart failure symptoms vary with severity and acuity:
Pulmonary Congestion Symptoms:
Shortness of breath at rest or with exertion
Orthopnoea (breathlessness when lying flat)
Paroxysmal nocturnal dyspnoea (sudden nighttime breathlessness)
Dry or wet cough
Systemic Congestion Symptoms:
Peripheral oedema (ankle and leg swelling)
Hepatomegaly (enlarged liver) with right upper quadrant discomfort
Weight gain (>2–3 kg over days)
Abdominal distension
Low Cardiac Output Symptoms:
Fatigue and weakness
Dizziness or syncope
Reduced exercise tolerance
Mental confusion (in severe cases)
Heart failure diagnosis and characterisation includes:
| Diagnostic Test | Specific Information Obtained |
|---|---|
| Clinical history and exam | Symptom characterisation and physical findings |
| 12-lead ECG | Rhythm, QRS duration, chamber enlargement |
| Chest X-ray | Pulmonary congestion, cardiomegaly |
| Transthoracic echo | Ejection fraction, chamber dimensions, valve function |
| BNP or NT-proBNP | Biomarker of ventricular stress |
| Coronary angiography | Identify CAD as aetiology |
| Right heart catheterization | Detailed haemodynamic assessment in complex cases |
| Cardiac MRI | Myocardial characterisation, ischaemia detection |
HFrEF Medical Management (Cornerstone Therapies):
| Medication Class | Mechanism and Benefits |
|---|---|
| ACE inhibitors or ARBs | Reduce afterload, prevent remodelling |
| Beta-blockers | Reduce heart rate, blood pressure, prevent arrhythmias |
| Aldosterone antagonists | Additional remodelling prevention, diuretic-sparing |
| SGLT2 inhibitors | Reduce hospitalisation, mortality in HFrEF |
| Hydralazine/nitrate | Vasodilation in special populations |
| Diuretics | Symptom relief in congestive states |
| Digoxin | Inotropic support in selected patients |
HFpEF Medical Management:
Blood pressure and heart rate control
Diuretics for congestion relief
Treatment of underlying comorbidities
Limited specific therapies; newer agents under investigation
Implantable Cardioverter Defibrillators (ICDs):
For patients at high sudden cardiac death risk
Particularly those with QRS duration >120 ms
Cardiac Resynchronisation Therapy (CRT):
For patients with wide QRS complex (>120 ms) and significant dysfunction
Improves cardiac output through sequential pacing
Inotropic Support:
Continuous dobutamine or milrinone infusions for end-stage disease
Improves symptoms in hospitalised patients
Mechanical Circulatory Support:
Left ventricular assist devices (LVADs) for select patients
Bridge to transplantation or destination therapy
Heart Transplantation:
Definitive therapy for end-stage disease
Limited availability; careful patient selection required
Critical components of heart failure management:
Sodium restriction – Usually <2 grams daily
Fluid restriction – Typically 1–1.5 litres daily in advanced disease
Weight monitoring – Daily weights to detect fluid accumulation
Controlled exercise – Supervised cardiac rehabilitation
Sleep quality – Treatment of sleep disorders
Medication adherence – Critical for outcomes
Smoking cessation – Complete elimination
Alcohol limitation – Or complete avoidance
Livasa Hospital provides integrated heart failure services:
Specialist heart failure cardiologists
Nursing support and patient education
Dietitian counselling
Psychosocial support
Device clinics and remote monitoring
Palliative care integration when appropriate
Modern heart failure management achieves:
Reduced symptom burden and improved quality of life
Decreased hospitalisations
Improved survival (particularly HFrEF)
Enhanced exercise capacity
Delayed disease progression
Specialist heart failure management team
Access to all evidence-based medical therapies
Device therapy programs (ICD, CRT, LVAD evaluation)
Comprehensive monitoring and surveillance
Multidisciplinary approach to care
Livasa Hospital Mohali
Sector 71, Sahibzada Ajit Singh Nagar (SAS Nagar)
Mohali, Punjab – 160071
Phone: +91-80788 80788 (24/7 Emergency)
Website: www.livasahospitals.com
Call +91-80788 80788 to enrol in the heart failure management program at Livasa Hospital.
+91 80788 80788
Livasa Healthcare Group Corporate Office,Phase-8, Industrial Area, Sector 73, Sahibzada Ajit Singh Nagar, Punjab 160071
livasacare@livasahospitals.in
| Mohali | +91-99888 23456 |
| Amritsar | +91-99887 49494 |
| Hoshiarpur | +91-99883 35353 |
| Nawanshahr | +91-75081 82337 |
| Khanna | +91-98888 05394 |